Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about MAPK11: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Gene Symbol | MAPK11 |
| Full Name | Mitogen-Activated Protein Kinase 11 |
| Aliases | Mitogen-activated protein kinase 11 (p38β) |
| Chromosome | 22q12.1 |
| Function | is a major signaling cascade activated by cellular stress and pro-inflammatory cytokines. |
| Molecular Weight | 41 kDa |
| Pathways | MAPK, MAPK pathway |
| UniProt ID | [Q16643](https://www.uniprot.org/uniprot/Q16643) |
| GeneCards | MAPK11 |
| Human Protein Atlas | MAPK11 |
| Environmental stress | UV radiation, oxidative stress, hypoxia |
| Inflammatory cytokines | IL-1β, TNF-α, IL-6 |
| Growth factors | Some growth factor signaling pathways |
| Pathogen-associated molecules | LPS through TLR signaling |
| Microglial activation | Controls pro-inflammatory cytokine production |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Neuroinflammation, Stroke |
| Known Drugs/Compounds | Losmapimod |
| KG Connections | 1 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
A["MAPK11<br/>(p38beta MAPK)"]
B["Cellular Stress<br/>Stimuli"]
C["MKK3/MKK6<br/>Kinases"]
D["ATF2<br/>Transcription Factor"]
E["CREB<br/>Transcription Factor"]
F["Pro-inflammatory<br/>Cytokines"]
G["Neuronal<br/>Apoptosis"]
H["Synaptic<br/>Dysfunction"]
I["Neurodegeneration"]
J["Alzheimer's<br/>Disease"]
K["Parkinson's<br/>Disease"]
L["Losmapimod<br/>Inhibitor"]
M["Oxidative<br/>Stress"]
N["Tau<br/>Phosphorylation"]
B -->|"activates"| C
C -->|"phosphorylates"| A
M -->|"activates"| A
A -->|"phosphorylates"| D
A -->|"phosphorylates"| E
A -->|"promotes"| F
A -->|"induces"| G
A -->|"impairs"| H
A -->|"phosphorylates"| N
F -->|"contributes to"| I
G -->|"leads to"| I
H -->|"contributes to"| I
N -->|"promotes"| I
I -->|"manifests as"| J
I -->|"manifests as"| K
L -->|"inhibits"| A
classDef central fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px
classDef pathological fill:#3a1a1a,stroke:#ef5350,stroke-width:2px
classDef regulatory fill:#2a1a3a,stroke:#ce93d8,stroke-width:2px
classDef disease fill:#3a2a1a,stroke:#ffa726,stroke-width:2px
classDef therapeutic fill:#1a3a2a,stroke:#81c784,stroke-width:2px
class A central
class F,G,H,I,M,N pathological
class C,D,E regulatory
class J,K disease
class L therapeutic
class B pathological| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| Losmapimod | inhibits | drug | 0.90 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity